Currax Sees Demand for Weight-Loss Drug Contrave Growing [J-C__Mdf7uU]

Currax Sees Demand for Weight-Loss Drug Contrave Growing [J-C__Mdf7uU]

| 1h 28m 28s | Video has closed captioning.

Currax Pharmaceuticals CEO George Hampton talks about the demand for the FDA-approved obesity drug Contrave. Demand is growing fast. He is on "Bloomberg Open Interest." -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: Visit for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X: Facebook: Instagram: Connect with Bloomberg Business on: X: Facebook: Instagram: TikTok: Reddit: LinkedIn: More from Bloomberg: Bloomberg Radio: Bloomberg Surveillance: Bloomberg Politics: Bloomberg Originals: Watch more on YouTube: Bloomberg Technology: Bloomberg Originals: Bloomberg Quicktake: Bloomberg Espanol: Bloomberg Podcasts: #does oprah have keto gummies #protein pills for weight loss